SRI KRISHNA PHARMACEUTICALS LTD UNI

SRI KRISHNA PHARMACEUTICALS LTD is a Manufacturer.

Company Introduction:

SRI KRISHNA PHARMACEUTICALS LTD is a prominent pharmaceutical company based in India. Established in 1974, it has grown to become a significant global player in the pharmaceutical industry. The company primarily manufactures Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and Finished Dosage Forms (FDFs).

SRI KRISHNA PHARMACEUTICALS LTD operates multiple state-of-the-art manufacturing facilities that comply with various international regulatory standards, including those from the US FDA, EDQM, KFDA, and WHO. The company is recognized for its robust research and development capabilities, its commitment to quality, and its focus on producing affordable and high-quality pharmaceutical products for markets across the globe. It serves a wide range of therapeutic areas and maintains a strong presence in both regulated and semi-regulated markets.

Products Manufactured or Sold:

Sri Krishna Pharmaceuticals Ltd. (SKPL) is a leading Indian pharmaceutical company primarily involved in the manufacturing and sale of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage formulations.

Active Pharmaceutical Ingredients (APIs):

The company produces a wide array of APIs, which are the key chemical components of pharmaceutical drugs. Some of their extensively manufactured APIs include:

Paracetamol (Acetaminophen)

Ibuprofen

Metformin Hydrochloride

Gabapentin

Pregabalin

Aspirin

Atenolol

Ranitidine Hydrochloride

Domperidone

Azithromycin

Ciprofloxacin

Montelukast Sodium

Rosuvastatin Calcium

Finished Dosage Formulations:

SKPL also manufactures various finished dosage forms, which are the final pharmaceutical products prepared for patient consumption. These typically encompass:

Tablets

Capsules

Oral Liquids

Their finished products serve diverse therapeutic areas, including pain and fever management, diabetes, neurological conditions, cardiovascular health, anti-infectives, and respiratory disorders.